Compare ALKS & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | HSIC |
|---|---|---|
| Founded | 1987 | 1932 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 9.8B |
| IPO Year | 2012 | 1996 |
| Metric | ALKS | HSIC |
|---|---|---|
| Price | $43.72 | $84.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 16 |
| Target Price | $43.43 | ★ $85.07 |
| AVG Volume (30 Days) | ★ 1.3M | 834.0K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.21 |
| EPS | N/A | ★ 1.74 |
| Revenue | $1,475,899,000.00 | ★ $13,201,995,000.00 |
| Revenue This Year | $24.26 | $6.12 |
| Revenue Next Year | $4.47 | $3.64 |
| P/E Ratio | ★ N/A | $48.87 |
| Revenue Growth | N/A | ★ 5.94 |
| 52 Week Low | $26.99 | $61.97 |
| 52 Week High | $55.67 | $92.18 |
| Indicator | ALKS | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 32.05 | 36.83 |
| Support Level | $36.25 | $82.77 |
| Resistance Level | $51.25 | $88.78 |
| Average True Range (ATR) | 1.39 | 1.74 |
| MACD | -0.10 | -0.59 |
| Stochastic Oscillator | 5.25 | 13.79 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.